-
1
-
-
0004008434
-
-
John Wright-PSG Inc.: Littleton, MA, (2nd edition 1985; Mosby-Year Book, Inc., St. Louis, MO. 3rd edition 1996; Springer: New York, NY. 3rd edition, 1998)
-
Friedman L, Furberg C, DeMets D. Fundamentals of Clinical Trials. John Wright-PSG Inc.: Littleton, MA, 1981 (2nd edition 1985; Mosby-Year Book, Inc., St. Louis, MO. 3rd edition 1996; Springer: New York, NY. 3rd edition, 1998).
-
(1981)
Fundamentals of Clinical Trials
-
-
Friedman, L.1
Furberg, C.2
DeMets, D.3
-
5
-
-
0023874973
-
Organization, review, and administration of cooperative studies
-
Greenberg Report
-
Greenberg Report: Organization, review, and administration of cooperative studies. Controlled Clinical Trials 1988; 9:137-148.
-
(1988)
Controlled Clinical Trials
, vol.9
, pp. 137-148
-
-
-
6
-
-
0019564664
-
Practical aspects of decision making in clinical trials: The Coronary Drug Project as a case study
-
Coronary Drug Project Research Group
-
Coronary Drug Project Research Group: Practical aspects of decision making in clinical trials: The Coronary Drug Project as a case study. Controlled Clinical Trials 1981; 1:363-376.
-
(1981)
Controlled Clinical Trials
, vol.1
, pp. 363-376
-
-
-
7
-
-
0035092538
-
The role of an independent statistical analysis center in the industry-modified National Institutes of Health model
-
Fisher M, Roecker EB, DeMets D. The role of an independent statistical analysis center in the industry-modified National Institutes of Health model. Drug Information Journal 2001; 35(1):115-29.
-
(2001)
Drug Information Journal
, vol.35
, Issue.1
, pp. 115-129
-
-
Fisher, M.1
Roecker, E.B.2
DeMets, D.3
-
8
-
-
0021025847
-
Monitoring of the data for evidence of adverse or beneficial treatment effects
-
Canner PL. Monitoring of the data for evidence of adverse or beneficial treatment effects. Controlled Clinical Trials 1983; 4:467-483.
-
(1983)
Controlled Clinical Trials
, vol.4
, pp. 467-483
-
-
Canner, P.L.1
-
9
-
-
0029591767
-
The Data and Safety Monitoring Board and acquired immune deficiency syndrome (AIDS) clinical trials
-
DeMets DL, Fleming TR, Whitley RJ, Childress JF, Ellenberg SS, Foulkes M, Mayer KH, O'Fallon J, Pollard RB, Rahal JJ, Sande M, Straus S, Walters L, Whitley-Williams P. The Data and Safety Monitoring Board and acquired immune deficiency syndrome (AIDS) clinical trials. Controlled Clinical Trials 1995; 16:408-421.
-
(1995)
Controlled Clinical Trials
, vol.16
, pp. 408-421
-
-
DeMets, D.L.1
Fleming, T.R.2
Whitley, R.J.3
Childress, J.F.4
Ellenberg, S.S.5
Foulkes, M.6
Mayer, K.H.7
O'Fallon, J.8
Pollard, R.B.9
Rahal, J.J.10
Sande, M.11
Straus, S.12
Walters, L.13
Whitley-Williams, P.14
-
10
-
-
23444434093
-
The early termination of clinical trials: Causes, consequences, and control - With special reference to trials in the field of arrhythmias and sudden death
-
Task Force of the Working Group on Arrhythmias of the European Society of Cardiology
-
Task Force of the Working Group on Arrhythmias of the European Society of Cardiology: The early termination of clinical trials: Causes, consequences, and control - With special reference to trials in the field of arrhythmias and sudden death. Circulation 1994; 89(6):2892-2907.
-
(1994)
Circulation
, vol.89
, Issue.6
, pp. 2892-2907
-
-
-
11
-
-
0037108141
-
Monitoring clinical trials: Issues and controversies regarding confidentiality
-
Fleming TR, Ellenberg S, DeMets DL. Monitoring clinical trials: issues and controversies regarding confidentiality. Statistics in Medicine 2002; 21:2843-51.
-
(2002)
Statistics in Medicine
, vol.21
, pp. 2843-2851
-
-
Fleming, T.R.1
Ellenberg, S.2
DeMets, D.L.3
-
13
-
-
0034648728
-
Protecting research subjects - What must be done
-
Shalala D. Protecting research subjects - what must be done. New England J Med 2000; 43(11): 808-10.
-
(2000)
New England J. Med.
, vol.43
, Issue.11
, pp. 808-810
-
-
Shalala, D.1
-
14
-
-
59449090974
-
NIH policy for data and safety monitoring
-
National Institutes of Health June 10
-
National Institutes of Health. NIH policy for data and safety monitoring. NIH Guide, June 10, 1998. http://grants2.nih.gov/grants/guide/notice-files/not98-084.html
-
(1998)
NIH Guide
-
-
-
15
-
-
0242571709
-
Draft Guidance for Clinical Trial Sponsors: On the Establishment and Operation of Clinical Trial Data Monitoring Committees
-
Nov 15
-
Draft Guidance for Clinical Trial Sponsors: On the Establishment and Operation of Clinical Trial Data Monitoring Committees. Nov 15, 2001. http://www.fda.gov/cber/guidelines.htm
-
(2001)
-
-
-
16
-
-
0028129495
-
The case against independent monitoring committees
-
Harrington D, Crowley J, George SL, Pajak T, Redmond C, Wieand HS. The case against independent monitoring committees. Statistics in Medicine 1994; 13(13/14):1411-1414.
-
(1994)
Statistics in Medicine
, vol.13
, Issue.13-14
, pp. 1411-1414
-
-
Harrington, D.1
Crowley, J.2
George, S.L.3
Pajak, T.4
Redmond, C.5
Wieand, H.S.6
-
17
-
-
2442686637
-
Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?
-
Ellenberg S, George S. Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership? Statistics in Medicine, 2004; 23:1503-1505.
-
(2004)
Statistics in Medicine
, vol.23
, pp. 1503-1505
-
-
Ellenberg, S.1
George, S.2
|